Page last updated: 2024-08-16

technetium tc 99m sestamibi and Coronary Restenosis

technetium tc 99m sestamibi has been researched along with Coronary Restenosis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Acikel, S; Bilgin, M; Gultekin, SS; Koca, G; Korkmaz, M; Sadic, M; Yeter, E1
Antoniucci, D; Bartorelli, A; Bolognese, L; Colombo, A; Fernandez-Pereira, C; Hempel, A; Migliorini, A; Moschi, G; Parodi, G; Rodriguez, A; Santoro, GM; Valenti, R; Vigo, F1
Bartunek, J; De Bondt, P; De Bruyne, B; Heyndrickx, G; Lootens, N; Mansour, S; Van Haute, I; Vandekerckhove, B; Vanderheyden, M; Wijns, W1
Amsler, B; Buser, PT; Kaiser, CA; Maeder, MT; Nietlispach, FP; Pfisterer, ME; Roser, HW; Roth, J; Weilenmann, D; Zellweger, MJ1

Trials

2 trial(s) available for technetium tc 99m sestamibi and Coronary Restenosis

ArticleYear
A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction.
    Journal of the American College of Cardiology, 2003, Dec-03, Volume: 42, Issue:11

    Topics: Abciximab; Adult; Aged; Antibodies, Monoclonal; Anticoagulants; Chemotherapy, Adjuvant; Coronary Restenosis; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Radionuclide Imaging; Stents; Technetium Tc 99m Sestamibi

2003
Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety.
    Circulation, 2005, Aug-30, Volume: 112, Issue:9 Suppl

    Topics: AC133 Antigen; Antigens, CD; Case-Control Studies; Chordae Tendineae; Coronary Circulation; Coronary Restenosis; Coronary Vessels; Feasibility Studies; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycoproteins; Hematopoietic Stem Cell Transplantation; Humans; Injections, Intra-Arterial; Male; Middle Aged; Myocardial Infarction; Peptides; Positron-Emission Tomography; Radiopharmaceuticals; Stents; Stroke Volume; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ultrasonography; Ventricular Function, Left

2005

Other Studies

2 other study(ies) available for technetium tc 99m sestamibi and Coronary Restenosis

ArticleYear
The value of transient ischemic dilation for detecting restenosis after coronary artery revascularization.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2018, Volume: 25, Issue:2

    Topics: Aged; Constriction, Pathologic; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Dilatation; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Perfusion Imaging; Myocardial Revascularization; Percutaneous Coronary Intervention; Recurrence; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon

2018
Long-term outcomes after intracoronary Beta-irradiation for in-stent restenosis in bare-metal stents.
    The Journal of invasive cardiology, 2008, Volume: 20, Issue:4

    Topics: Aged; Brachytherapy; Coronary Restenosis; Female; Gamma Rays; Humans; Male; Middle Aged; Myocardial Revascularization; Prospective Studies; Saphenous Vein; Stents; Technetium Tc 99m Sestamibi; Time Factors; Tomography, Emission-Computed, Single-Photon; Treatment Outcome

2008